Filing Flows › Bio-Rad Laboratories (BIO) › Life Science revenue
Bio-Rad Laboratories (BIO) Life Science revenue by quarter
Bio-Rad Laboratories' Life Science revenue was $255M in Q3 2026 (third quarter 2026), +1% from Q2 2026. Over the last 7 quarters it ranged from $228M (Q1 2026) to $268M (Q4 2025).
| Quarter | Life Science revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $255M | +1% | -3% |
| Q2 2026 | $252M | +10% | -4% |
| Q1 2026 | $228M | -15% | 0% |
| Q4 2025 | $268M | +2% | — |
| Q3 2025 | $262M | -0.4% | — |
| Q2 2025 | $263M | +15% | — |
| Q1 2025 | $229M | — | — |
Q3 2026 at a glance
Bio-Rad Laboratories, Q3 2026: revenue $656M (+0.5% year over year), operating margin -7.6%, net earnings $459M, operating cash flow $96.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Bio-Rad Laboratories' Life Science revenue?
Bio-Rad Laboratories' Life Science revenue was $255M in Q3 2026 (third quarter 2026), +1% from Q2 2026.
How has Bio-Rad Laboratories' Life Science revenue changed?
Over the last 7 quarters it ranged from $228M (Q1 2026) to $268M (Q4 2025).